Skip to main content
. 2020 Sep 30;2(4):581–595. doi: 10.1016/j.jaccao.2020.09.001

Central Illustration.

Central Illustration

Key Elements of the Cardiovascular Cell Therapy Research Network’s SENECA Trial

Key elements highlighted in the Cardiovascular Cell Therapy Research Network’s SENECA trial include the etiology of anthracycline-induced cardiomyopathy, in survivors of diverse cancers, and the notable findings demonstrating safety and feasibility of transendocardial administration allogeneic mesenchymal stromal cells.